Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
China Resources Pharmaceutical Group Ltd. ( (HK:3320) ) has issued an announcement.
China Resources Pharmaceutical Group Limited has declared a final ordinary dividend of RMB 0.122 per share for the financial year ended 31 December 2025, subject to shareholder approval on 29 May 2026. The dividend will be payable in Hong Kong dollars by default at HKD 0.139 per share, with shareholders offered a partial currency election to receive the payout in renminbi.
The ex‑dividend date is set for 3 June 2026, with the register closing from 5 to 8 June 2026 and a record date of 8 June 2026 to determine eligible shareholders. Payment is scheduled for 21 July 2026, underscoring the company’s continued capital return to investors and providing income visibility for shareholders in both Hong Kong and mainland China markets.
The most recent analyst rating on (HK:3320) stock is a Hold with a HK$5.00 price target. To see the full list of analyst forecasts on China Resources Pharmaceutical Group Ltd. stock, see the HK:3320 Stock Forecast page.
More about China Resources Pharmaceutical Group Ltd.
China Resources Pharmaceutical Group Limited is a Hong Kong‑listed pharmaceutical company engaged in the manufacture, distribution and retail of medicines and healthcare products. It operates within the broader healthcare and pharma sector, serving mainland China and regional markets through a portfolio spanning prescription drugs, over‑the‑counter products and related services.
Average Trading Volume: 9,985,830
Technical Sentiment Signal: Sell
Current Market Cap: HK$27.83B
See more data about 3320 stock on TipRanks’ Stock Analysis page.